Fatty liver disease (MASLD/MASH) trials in Iran

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseNot yet taking people in Iran
  The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

  Where

  Tabriz

  Age

  18 years to 50 years

  People

  44

  Run by

  Tabriz University of Medical Sciences

  See details and how to joinNCT07740109